Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to ApoptosisYunfei Zhou, Michael G. Brattain|Cancer Research|2006Cited by 96
Sumoylation Inhibits Cleavage of Sp1 N-terminal Negative Regulatory Domain and Inhibits Sp1-dependent TranscriptionMary L. Spengler, Michael G. Brattain|Journal of Biological Chemistry|2006Cited by 86
Colon carcinoma cells harboring <i>PIK3CA</i> mutations display resistance to growth factor deprivation induced apoptosisJing Wang, Michael G. Brattain|Molecular Cancer Therapeutics|2007Cited by 61
Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer CellsYi Hu, Michael G. Brattain|Journal of Biological Chemistry|2005Cited by 25